Cannabis Deal

Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to acquire the exclusive rights for advanced cannabis products. Under the deal, current Remidose customers will be serviced through MediPharm starting August 2024, including Canadian direct-to-patient medical platforms and international medical distributors. MediPharm intends to utilize its existing GMP infrastructure, customer channels and wellness sales expertise to expand the customer base of these advanced products in Canada and internationally.
New Cannabis Partnership Set To Revolutionize Nevada's Market As Nabis Acquires Blackbird
Nabis, a cannabis wholesale platform, has announced its acquisition of Nevada-based distribution solution Blackbird, aiming to enhance efficiency and customer experience in the state's cannabis supply chain. The move combines Nabis' technology and exclusive brands with Blackbird's network of operators and retailers. The partnership is expected to strengthen operations and streamline processes, providing a unified wholesaling experience in the region. Drea Ballard from Blackbird views this as a positive step towards a brighter future for the cannabis industry in Nevada. The acquisition highlights Nabis' commitment to revolutionizing cannabis commerce by leveraging the strengths of both companies. Nabis, founded in 2018, envisions expanding nationally and internationally. Vince C. Ning, Nabis' founder, sees the acquisition as leading the industry towards a new era of cannabis commerce, combining the best of both companies to drive innovation and efficiency in the marketplace.